多导睡眠图与简化呼吸监测及护士滴定在无创通气设置中的比较:一项初步随机临床试验
LRM组PaCO2降低-0.88 kPa(95%CI -1.52至-0.24),PSG组降低-0.36 kPa(95%CI -0.96至0.24),提示LRM可能有效,支持开展更大规模临床试验。
要点
- 在COPD-OSA重叠患者中,LRM指导的NIV设置3个月PaCO2降低-0.88 kPa。
- PSG指导的NIV设置PaCO2降低-0.36 kPa,95%CI跨0。
- 初步数据支持开展LRM与PSG比较的临床有效性试验。
核心结论
- 初步数据支持开展临床试验以评估LRM和PSG在COPD-OSA重叠患者中建立NIV的临床有效性。
研究设计与样本
- 比较PSG、简化呼吸监测(LRM)和护士滴定指导的NIV设置。
- 主要结局为3个月时日间动脉血二氧化碳分压(PaCO2)的变化。
主要发现
- 3个月时,LRM组PaCO2降低-0.88 kPa(95%CI -1.52至-0.24 kPa)。
- 3个月时,PSG组PaCO2降低-0.36 kPa(95%CI -0.96至0.24 kPa)。
临床怎么用
- 对于COPD-OSA重叠患者,可考虑使用LRM指导NIV设置,但需进一步临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Polysomnography (PSG) is recommended for non-invasive ventilation (NIV) set-up in patients with chronic respiratory failure. In this pilot randomised clinical trial, we compared the physiological effectiveness of NIV set-up guided by PSG to limited respiratory monitoring (LRM) and nurse-led titration in patients with COPD-obstructive sleep apnoea (OSA) overlap. The principal outcome of interest was change in daytime arterial partial pressure of carbon dioxide (PaCO2) at 3 months. Fourteen patients with daytime PaCO2 >6 kPa and body mass index >30 kg/m2 were recruited. At 3 months, PaCO2 was reduced by -0.88 kPa (95% CI -1.52 to -0.24 kPa) in the LRM group and by -0.36 kPa (95% CI -0.96 to 0.24 kPa) in the PSG group. These pilot data provide support to undertake a clinical trial investigating the clinical effectiveness of attended limited respiratory monitoring and PSG to establish NIV in patients with COPD-OSA overlap. TRIAL NUMBER: Results, NCT02444806.
引用
- Patout M, Arbane G, Cuvelier A, et al. Polysomnography versus limited respiratory monitoring and nurse-led titration to optimise non-invasive ventilation set-up: a pilot randomised clinical trial. Thorax. 2018. PMID: 29602814. doi:10.1136/thoraxjnl-2017-211067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。